{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:15:23Z","timestamp":1783937723802,"version":"3.55.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Guillain\u2013Barr\u00e9 syndrome (GBS) is a potentially life-threatening post-infectious autoimmune disease characterized by rapidly progressive symmetrical weakness of the extremities. Herein, we report a case of GBS associated with drug poisoning complicated by <jats:italic>Klebsiella pneumoniae<\/jats:italic> infection. A 38-year-old woman was admitted to the intensive care unit after taking an overdose of amitriptyline and was later diagnosed with coma, <jats:italic>Klebsiella pneumoniae<\/jats:italic> infection, and septic shock. Thirteen days after admission, she was diagnosed with GBS based on acute muscle pain, flaccid paralysis, hyporeflexia, reduced amplitude of compound muscle action potential, and albuminocytologic dissociation in the cerebrospinal fluid. GBS rarely occurs after a drug overdose and septic shock, and this is the first report of a rapidly progressive GBS following amitriptyline overdose and severe <jats:italic>Klebsiella pneumoniae<\/jats:italic> infection.<\/jats:p>","DOI":"10.3389\/fmed.2022.991182","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T05:13:01Z","timestamp":1664860381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Rapidly progressive Guillain\u2013Barr\u00e9 syndrome following amitriptyline overdose and severe Klebsiella pneumoniae infection: A case report and literature review"],"prefix":"10.3389","volume":"9","author":[{"given":"Boyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","article-title":"Guillain-Barr\u00e9 syndrome","volume":"352","author":"Hahn","year":"1998","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00415-020-10133-w","article-title":"SARS-CoV-2 associated Guillain-Barr\u00e9 syndrome","volume":"268","author":"Pelea","year":"2021","journal-title":"J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e249749","DOI":"10.1136\/bcr-2022-249749","article-title":"Rare occurrence of Guillain-Barr\u00e9 syndrome after moderna vaccine","volume":"15","author":"Bijoy George","year":"2022","journal-title":"BMJ Case Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-021-02301-0","article-title":"Autoantibody screening in Guillain-Barr\u00e9 syndrome","volume":"18","author":"Lleix\u00e0","year":"2021","journal-title":"J Neuroinflammation."},{"key":"B7","author":"Nguyen","year":"2021","journal-title":"Guillain Barre Syndrome"},{"key":"B8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.54.3.620","article-title":"Mild forms of Guillain-Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands","volume":"54","author":"Van Koningsveld","year":"2000","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s13311-022-01253-4","article-title":"Immunoglobulin and monoclonal antibody therapies in Guillain-Barr\u00e9 syndrome","volume":"19","author":"Rajabally","year":"2022","journal-title":"Neurotherapeutics."},{"key":"B11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2016-314862","article-title":"Treatment dilemmas in Guillain-Barr\u00e9 syndrome","volume":"88","author":"Verboon","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"CD001798","DOI":"10.1002\/14651858.CD001798.pub3","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the quality standards subcommittee of the American academy of neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 study group","volume":"326","author":"van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00003246-199303000-00023","article-title":"Intensive management and treatment of severe Guillain-Barr\u00e9 syndrome","volume":"21","author":"Hund","year":"1993","journal-title":"Crit Care Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.991182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T05:13:03Z","timestamp":1664860383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.991182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":15,"alternative-id":["10.3389\/fmed.2022.991182"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.991182","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"article-number":"991182"}}